This invention discloses a 2-phenylimidazo[1,2-] α This paper describes
pyridine compounds, their preparation methods, and applications, belonging to the field of
pharmaceutical technology. These compounds use imidazo[1,2-α]
pyridine as the core skeleton and are prepared via a three-
step method: first, cyclization of 2-aminopyridine with hydroxyacetophenone yields intermediate LT1-6; then, etherification with a brominated
carboxylic acid ester yields LT7-48; finally,
hydroxylamine hydrolysis converts them into the target product HDDI1-42, which contains an isohydroxamic
acid group. Activity tests show that these compounds possess significant HDAC1 inhibitory activity and anti-tumor
cell proliferation activity.